CVAC
Price
$5.03
Change
-$0.09 (-1.76%)
Updated
Nov 21 closing price
Capitalization
1.13B
158 days until earnings call
Intraday BUY SELL Signals
URGN
Price
$25.87
Change
+$1.03 (+4.15%)
Updated
Nov 21 closing price
Capitalization
1.21B
109 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CVAC vs URGN

Header iconCVAC vs URGN Comparison
Open Charts CVAC vs URGNBanner chart's image
CureVac
Price$5.03
Change-$0.09 (-1.76%)
Volume$1.38M
Capitalization1.13B
UroGen Pharma
Price$25.87
Change+$1.03 (+4.15%)
Volume$773.74K
Capitalization1.21B
CVAC vs URGN Comparison Chart in %
CVAC
Daily Signal:
Gain/Loss:
URGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CVAC vs. URGN commentary
Nov 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVAC is a Hold and URGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 23, 2025
Stock price -- (CVAC: $5.03 vs. URGN: $25.87)
Brand notoriety: CVAC and URGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVAC: 253% vs. URGN: 65%
Market capitalization -- CVAC: $1.13B vs. URGN: $1.21B
CVAC [@Biotechnology] is valued at $1.13B. URGN’s [@Biotechnology] market capitalization is $1.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVAC’s FA Score shows that 1 FA rating(s) are green whileURGN’s FA Score has 0 green FA rating(s).

  • CVAC’s FA Score: 1 green, 4 red.
  • URGN’s FA Score: 0 green, 5 red.
According to our system of comparison, CVAC is a better buy in the long-term than URGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVAC’s TA Score shows that 4 TA indicator(s) are bullish while URGN’s TA Score has 6 bullish TA indicator(s).

  • CVAC’s TA Score: 4 bullish, 5 bearish.
  • URGN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, URGN is a better buy in the short-term than CVAC.

Price Growth

CVAC (@Biotechnology) experienced а -4.73% price change this week, while URGN (@Biotechnology) price change was +8.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +62.87%.

Reported Earning Dates

CVAC is expected to report earnings on Nov 24, 2025.

URGN is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
URGN($1.21B) has a higher market cap than CVAC($1.13B). URGN YTD gains are higher at: 142.911 vs. CVAC (47.507). CVAC has higher annual earnings (EBITDA): 239M vs. URGN (-119.79M). CVAC has more cash in the bank: 396M vs. URGN (196M). CVAC has less debt than URGN: CVAC (36M) vs URGN (125M). CVAC has higher revenues than URGN: CVAC (511M) vs URGN (91.9M).
CVACURGNCVAC / URGN
Capitalization1.13B1.21B94%
EBITDA239M-119.79M-200%
Gain YTD47.507142.91133%
P/E Ratio5.07N/A-
Revenue511M91.9M556%
Total Cash396M196M202%
Total Debt36M125M29%
FUNDAMENTALS RATINGS
URGN: Fundamental Ratings
URGN
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
87
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVACURGN
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
75%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CVAC
Daily Signal:
Gain/Loss:
URGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDSPX28.140.65
+2.36%
BlackRock Advantage SMID Cap Inv A
MWEMX48.990.95
+1.98%
MFS Global Equity R6
JVARX39.540.70
+1.80%
JPMorgan Value Advantage R5
MRIEX13.630.17
+1.26%
Meridian Hedged Equity Investor
GPIOX3.230.04
+1.25%
Grandeur Peak International Opps Inv